Zobrazeno 1 - 10
of 175 765
pro vyhledávání: '"CONJUGATE"'
Autor:
Fridh AC; Access and Value, Pfizer AB, Stockholm, Sweden., Palmborg A; Medical and Scientific Affairs, Pfizer AB, Stockholm, Sweden., Ta A; Evidence Value and Access, Cytel, London, UK., Freigofaite D; Evidence Value and Access, Cytel, Rotterdam, Netherlands., Warren S; Global Value and Evidence, Vaccines, Pfizer Inc, New York, NY, USA., Perdrizet J; Global Value and Evidence, Pfizer Canada, Kirkland, Canada.
Publikováno v:
Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2024 Dec 31; Vol. 20 (1), pp. 2400751. Date of Electronic Publication: 2024 Sep 15.
Autor:
Nampota-Nkomba N; Blantyre Malaria Project, Kamuzu University of Health Sciences, Blantyre, Malawi.; Graduate Program in Life Sciences, University of Maryland School of Medicine, Baltimore, MD, USA., Nyirenda OM; Blantyre Malaria Project, Kamuzu University of Health Sciences, Blantyre, Malawi., Mapemba V; Blantyre Malaria Project, Kamuzu University of Health Sciences, Blantyre, Malawi., Masonga R; Blantyre Malaria Project, Kamuzu University of Health Sciences, Blantyre, Malawi., Patel PD; Malawi-Liverpool-Wellcome Program, Kamuzu University of Health Sciences, Blantyre, Malawi., Misiri T; Malawi-Liverpool-Wellcome Program, Kamuzu University of Health Sciences, Blantyre, Malawi., Mwakiseghile F; Malawi-Liverpool-Wellcome Program, Kamuzu University of Health Sciences, Blantyre, Malawi., Wachepa R; Malawi-Liverpool-Wellcome Program, Kamuzu University of Health Sciences, Blantyre, Malawi., Ndaferankhande JM; Malawi-Liverpool-Wellcome Program, Kamuzu University of Health Sciences, Blantyre, Malawi., Lipenga B; Malawi-Liverpool-Wellcome Program, Kamuzu University of Health Sciences, Blantyre, Malawi., Patel P; Malawi-Liverpool-Wellcome Program, Kamuzu University of Health Sciences, Blantyre, Malawi., Banda H; Malawi-Liverpool-Wellcome Program, Kamuzu University of Health Sciences, Blantyre, Malawi., Oshinsky J; Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, USA., Pasetti MF; Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, USA., Heyderman RS; Malawi-Liverpool-Wellcome Program, Kamuzu University of Health Sciences, Blantyre, Malawi.; Department of Infection, Division of Infectious Diseases, University College London, London, UK., Jamka LP; Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, USA., Hosangadi D; Graduate Program in Life Sciences, University of Maryland School of Medicine, Baltimore, MD, USA., Datta S; Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, USA., Gordon MA; Malawi-Liverpool-Wellcome Program, Kamuzu University of Health Sciences, Blantyre, Malawi.; Malawi-Liverpool-Wellcome Program, University of Liverpool, Liverpool, UK., Neuzil KM; Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, USA.; Fogarty International Center, National Institute of Health, Bethesda, MD, USA., Laurens MB; Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, USA.
Publikováno v:
Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2024 Dec 31; Vol. 20 (1), pp. 2384760. Date of Electronic Publication: 2024 Sep 12.
Autor:
King LM; School of Public Health, University of California, Berkeley, 2121 Berkeley Way, Berkeley, CA 94704, United States. Electronic address: laura_king@berkeley.edu., Lewnard JA; School of Public Health, University of California, Berkeley, 2121 Berkeley Way, Berkeley, CA 94704, United States. Electronic address: jlewnard@berkeley.edu.
Publikováno v:
Vaccine [Vaccine] 2024 Dec 02; Vol. 42 (26), pp. 126310. Date of Electronic Publication: 2024 Sep 10.
Autor:
Sheikhi A; Department of Microbiology and Virology, Zanjan University of Medical Sciences, Zanjan, Iran.; Student Research Committee, Department of Medical Microbiology and Virology, School of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran., Shirmohammadpour M; Department of Microbiology and Virology, Zanjan University of Medical Sciences, Zanjan, Iran.; Student Research Committee, Department of Medical Microbiology and Virology, School of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran., Mahdei Nasirmahalleh N; Department of Medical Biochemistry, School of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran., Mirzaei B; Department of Microbiology and Virology, Zanjan University of Medical Sciences, Zanjan, Iran.
Publikováno v:
Frontiers in immunology [Front Immunol] 2024 Nov 20; Vol. 15, pp. 1483740. Date of Electronic Publication: 2024 Nov 20 (Print Publication: 2024).
Autor:
Lewnard JA; Center for Computational Biology, School of Public Health.; College of Statistics, Data Science, and Society.; Augmented Graduate Group in Computational Precision Health, University of California, Berkeley., Hong V; Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena., Grant LR; Pfizer Vaccines, Collegeville, Pennsylvania., Ackerson BK; Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena., Bruxvoort KJ; Department of Epidemiology, School of Public Health, University of Alabama at Birmingham., Pomichowski M; Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena., Arguedas A; Pfizer Vaccines, Collegeville, Pennsylvania., Cané A; Pfizer Vaccines, Collegeville, Pennsylvania., Jodar L; Pfizer Vaccines, Collegeville, Pennsylvania., Gessner BD; Pfizer Vaccines, Collegeville, Pennsylvania., Tartof SY; Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena.; Department of Health Systems Science, Kaiser Permanente Bernard J. Tyson School of Medicine, Pasadena, California.
Publikováno v:
The Journal of infectious diseases [J Infect Dis] 2024 Nov 15; Vol. 230 (5), pp. e1082-e1091.
Autor:
Lin M; Analytical Research & Development, Merck & Co., Inc., Rahway, NJ 07065, USA. Electronic address: Mingxiang.lin@merck.com., Deng JZ; Analytical Research & Development, Merck & Co., Inc., West Point, PA 19486, USA., Scapin G; NanoImaging Services, 4C Gill Street, Woburn, MA 01801, USA., Yuan Y; Analytical Research & Development, Merck & Co., Inc., West Point, PA 19486, USA., Gomez-Llorente Y; Discovery Chemistry, Merck & Co., Inc., Rahway, NJ 07065, USA., Tong W; Analytical Research & Development, Merck & Co., Inc., Rahway, NJ 07065, USA., Porambo R; Analytical Research & Development, Merck & Co., Inc., West Point, PA 19486, USA., Kong J; Schrodinger, New York, NY 10036, USA., Ikemoto N; J-STAR Research, Inc, 3001 Hadley Road, Suites 1-5A, South Plainfield, NJ 07080, USA., Lancaster C; Global Project & Alliance Mangement, Merck & Co., Inc, North Wales, PA 19454, USA., Kaelber J; Institute for Quantitative Biomedicine and Rutgers CryoEM & Nanoimaging Facility, Rutgers, the State University of New Jersey, Piscataway, NJ 08854, USA., Winters M; Vaccine Process & Development, Merck & Co., Inc., West Point, PA 19486, USA., Zhuang P; Bristol Meyers Squibb, New Brunswick, NJ, USA.
Publikováno v:
Vaccine [Vaccine] 2024 Nov 14; Vol. 42 (25), pp. 126067. Date of Electronic Publication: 2024 Jun 24.
Autor:
Wassil J; Vaxcyte, Inc., San Carlos, CA, USA. Electronic address: jim.wassil@vaxcyte.com., Sisti M; Vaxcyte, Inc., San Carlos, CA, USA., Fairman J; Vaxcyte, Inc., San Carlos, CA, USA., Rankin B; Accel Research, Deland, FL, USA., Clark J; Charlottesville Medical Research, Charlottesville, VA, USA., Bennett S; Vaxcyte, Inc., San Carlos, CA, USA., Johnson D; Vaxcyte, Inc., San Carlos, CA, USA., Migone TS; Vaxcyte, Inc., San Carlos, CA, USA., Nguyen K; Vaxcyte, Inc., San Carlos, CA, USA., Paschenko A; Vaxcyte, Inc., San Carlos, CA, USA., Sauer P; Vaxcyte, Inc., San Carlos, CA, USA., Iki S; Vaxcyte, Inc., San Carlos, CA, USA., Hanson ME; Vaxcyte, Inc., San Carlos, CA, USA., Simon JK; Vaxcyte, Inc., San Carlos, CA, USA.
Publikováno v:
Vaccine [Vaccine] 2024 Nov 14; Vol. 42 (25), pp. 126124. Date of Electronic Publication: 2024 Jul 17.
Autor:
Rademacher J; Klinik für Pneumologie und Infektiologie, Medizinische Hochschule Hannover (MHH), OE 6870, Carl-Neuberg-Str. 1, 30625, Hannover, Deutschland. rademacher.jessica@mh-hannover.de.
Publikováno v:
Innere Medizin (Heidelberg, Germany) [Inn Med (Heidelb)] 2024 Nov; Vol. 65 (11), pp. 1076-1081. Date of Electronic Publication: 2024 Sep 02.
Autor:
Hsiao A; Kaiser Permanente Vaccine Study Center, Oakland, CA, USA. Electronic address: Amber.Hyman@kp.org., Lewis N; Kaiser Permanente Vaccine Study Center, Oakland, CA, USA., Hansen J; Kaiser Permanente Vaccine Study Center, Oakland, CA, USA., Timbol J; Kaiser Permanente Vaccine Study Center, Oakland, CA, USA., Suaya JA; Heller School, Brandeis University, Waltham, MA, USA., Alexander-Parrish R; Pfizer Vaccine Medicines Development & Scientific Clinical Affairs, Collegeville, PA, USA., Grant LR; Pfizer Vaccine Medicines Development & Scientific Clinical Affairs, Collegeville, PA, USA., Gessner BD; Pfizer Vaccine Medicines Development & Scientific Clinical Affairs, Collegeville, PA, USA., Klein NP; Kaiser Permanente Vaccine Study Center, Oakland, CA, USA.
Publikováno v:
Vaccine [Vaccine] 2025 Jan 12; Vol. 44, pp. 126543. Date of Electronic Publication: 2024 Dec 04.
Autor:
Rosenthal M; Department of Health Policy and Management, Tulane University School of Public Health and Tropical Medicine, New Orleans, LA, United States., Stoecker C; Department of Health Policy and Management, Tulane University School of Public Health and Tropical Medicine, New Orleans, LA, United States. Electronic address: cfstoecker@tulane.edu., Leidner AJ; National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, United States., Cho BH; National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, United States., Pilishvili T; National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, United States., Kobayashi M; National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, United States.
Publikováno v:
Vaccine [Vaccine] 2025 Jan 12; Vol. 44, pp. 126567. Date of Electronic Publication: 2024 Dec 06.